Table 3.
In-hospital death and 2-year clinical outcomes.
| Total n = 11,161 |
Diabetic Patients | Non-Diabetic Patients | |||||
|---|---|---|---|---|---|---|---|
| Atypical n = 518 |
Typical n = 2585 |
p-Value | Atypical n = 868 |
Typical n = 7188 |
p-Value | ||
| In-hospital death | 388 (3.5) | 60 (11.6) | 98 (3.8) | <0.0001 | 67 (7.8) | 163 (2.3) | <0.0001 |
| Cardiac death | 329 (3.0) | 50 (9.7) | 79 (3.1) | <0.0001 | 56 (6.5) | 144 (2.0) | <0.0001 |
| Non-cardiac death | 59 (0.5) | 10 (1.9) | 19 (0.7) | 0.0200 | 11 (1.3) | 19 (0.3) | 0.0002 |
| Two-year clinical outcomes | |||||||
| POCE | 1924 (17.2) | 193 (37.3) | 529 (20.5) | <0.0001 | 237 (27.3) | 965 (13.4) | <0.0001 |
| All-cause of death | 1077 (9.7) | 153 (29.5) | 294 (11.4) | <0.0001 | 177 (20.4) | 453 (6.3) | <0.0001 |
| Any MI | 300 (2.7) | 29 (5.6) | 104 (4.0) | 0.1062 | 30 (3.5) | 137 (1.9) | 0.0025 |
| Any revascularization | 836 (7.5) | 43 (8.3) | 238 (9.2) | 0.5120 | 60 (6.9) | 495 (6.9) | 0.9772 |
| DOCE | 1020 (9.1) | 129 (24.9) | 292 (11.3) | <0.0001 | 159 (18.3) | 440 (6.1) | <0.0001 |
| Cardiac death | 755 (6.8) | 109 (21.0) | 206 (8.0) | <0.0001 | 130 (15.0) | 310 (4.3) | <0.0001 |
| Target vessel MI | 117 (1.1) | 10 (1.9) | 43 (1.7) | 0.6685 | 13 (1.5) | 51 (0.7) | 0.0135 |
| TLR | 246 (2.2) | 15 (2.9) | 78 (3.0) | 0.8822 | 27 (3.1) | 126 (1.8) | 0.0056 |
POCE, patient-oriented composite endpoint; MI, myocardial infarction; DOCO, device-oriented composite endpoint; TLR, target lesion revascularization.